Arq, Inc.
Arq Reports Third Quarter 2026 Results
Achieved record quarterly revenue of $38.2 million (+9% YoY) and Net income of $2.5 million
Source
From GlobeNewswire
21 releases originally issued via GlobeNewswire. The issuing organizations are responsible for their content.
Dirtt Environmental Solutions Ltd
DIRTT Reports Third Quarter 2026 Financial Results
Cytek Biosciences, Inc.
Cytek Biosciences Reports Third Quarter 2026 Financial Results
FACT II Acquisition Corp.
FACT II Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
Hp Inc
HP Inc. Appoints Emma Walmsley as Chief Executive Officer
Bruce Broussard to Succeed Chip Bergh as Chair of the Board
electroCore, Inc.
electroCore Announces Third Quarter 2026 Financial Results
Third quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025
Riot Platforms, Inc.
Riot Platforms Reports Third Quarter 2026 Financial Results and Strategic Highlights
Executed a 15-year, 910 critical IT MW triple-net powered land lease with a leading Frontier AI Lab at Corsicana, representing approximately $28…
Shoals Technologies Group, Inc.
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026
–Quarterly Revenue of $195.3 million –
Geron Corp
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026
SLR Investment Corp.
SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results
Net Investment Income of $0.33 Per Share for Q3 2026;
Neutron Holdings, Inc.
Lime Announces Third Quarter 2026 Financial Results
Record Third Quarter Revenue of $361 Million, Up 20% YoY
InnovAge Holding Corp.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2026
Xometry, Inc.
Xometry Reports Record Third Quarter 2026 Results
Q3 revenue increased 40% year-over-year to a record $252 million, driven by robust marketplace growth.
Teva Pharmaceutical Industries Ltd
Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion
COMPANY STRENGTHENS NEUROSCIENCE LEADERSHIP WITH WELTRUZA™ LAUNCH AND STRATEGIC ADDITION OF BXCL-501